Pathologic Complete Response and Individual Patient Prognosis After Neoadjuvant Chemotherapy Plus Anti-Human Epidermal Growth Factor Receptor 2 Therapy of Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer

  1. van Mackelenbergh, M.T.
  2. Loibl, S.
  3. Untch, M.
  4. Buyse, M.
  5. Geyer, C.E.
  6. Gianni, L.
  7. Schneeweiss, A.
  8. Conte, P.
  9. Piccart, M.
  10. Bonnefoi, H.
  11. Jackisch, C.
  12. Nekljudova, V.
  13. Tang, G.
  14. Valagussa, P.
  15. Neate, C.
  16. Gelber, R.
  17. Poncet, C.
  18. Squifflet, P.
  19. Saad, E.D.
  20. Heinzmann, D.
  21. Denkert, C.
  22. Rastogi, P.
  23. Cortes, J.
  24. Guarneri, V.
  25. de Azambuja, E.
  26. Cameron, D.
  27. Ismael, G.
  28. Wolmark, N.
  29. Cortazar, P.
  30. Show all authors +
Journal:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Year of publication: 2023

Volume: 41

Issue: 16

Pages: 2998-3008

Type: Article

DOI: 10.1200/JCO.22.02241 GOOGLE SCHOLAR